Status:
COMPLETED
Uterocervical Angle: a Screening Tool That Estimates the Latent Phase Duration in Post Term Pregnancies
Lead Sponsor:
Sanliurfa Mehmet Akif Inan Education and Research Hospital
Conditions:
Post Term Pregnancy
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
To evaluate the performance of uterocervical angle (UCA) in the prediction of latent phase duration in post term pregnancies
Eligibility Criteria
Inclusion
- Patients with singleton pregnancies
- Post term pregnancies
- Patients with vertex presentation,
- Patients with intact membranes
- Patients with no uterine contractions
Exclusion
- women with BMI \>30,
- multiparity and multiple pregnancies,
- patients with macrosomia (\>4500 gr),
- patients with major fetal congenital abnormality or fetal death and any contraindications to vaginal birth (e.g. active genital herpes),
- patients with abnormal Pap smears,
- patients with a history of previous cesarean section, myomectomy, hysteroscopic surgeries, dilatation and curettages, loop electrosurgical excision procedures, and cervical conization.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04848701
Start Date
June 1 2020
End Date
October 30 2020
Last Update
April 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nefise Nazlı Yenigül
Bursa, Turkey (Türkiye), 16110